BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 38203561)

  • 1. Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility.
    Oketch DJA; Giulietti M; Piva F
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
    Peng J; Sun BF; Chen CY; Zhou JY; Chen YS; Chen H; Liu L; Huang D; Jiang J; Cui GS; Yang Y; Wang W; Guo D; Dai M; Guo J; Zhang T; Liao Q; Liu Y; Zhao YL; Han DL; Zhao Y; Yang YG; Wu W
    Cell Res; 2019 Sep; 29(9):725-738. PubMed ID: 31273297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene copy number variation and common human disease.
    Fanciulli M; Petretto E; Aitman TJ
    Clin Genet; 2010 Mar; 77(3):201-13. PubMed ID: 20002459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer.
    Zhu LL; Wu Z; Li RK; Xing X; Jiang YS; Li J; Wang YH; Hu LP; Wang X; Qin WT; Sun YW; Zhang ZG; Yang Q; Jiang SH
    Int J Biol Sci; 2021; 17(1):107-118. PubMed ID: 33390837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis of intra-tumoural and inter-tumoural heterogeneity in pancreatic ductal adenocarcinoma.
    Liu X; Wang W; Liu X; Zhang Z; Yu L; Li R; Guo D; Cai W; Quan X; Wu H; Dai M; Liang Z
    Clin Transl Med; 2022 Jan; 12(1):e670. PubMed ID: 35061935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma.
    Detlefsen S; Boldt HB; Burton M; Thomsen MM; Rasmussen LG; Ørbeck SV; Pfeiffer P; Mortensen MB; de Stricker K
    Hum Pathol; 2023 Dec; 142():68-80. PubMed ID: 37977512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epigenetics in pancreatic ductal adenocarcinoma.
    Pandey S; Gupta VK; Lavania SP
    Epigenomics; 2023 Jan; 15(2):89-110. PubMed ID: 36647796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma.
    Samuel N; Sayad A; Wilson G; Lemire M; Brown KR; Muthuswamy L; Hudson TJ; Moffat J
    Pancreas; 2013 Aug; 42(6):1016-26. PubMed ID: 23851435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
    Zhao L; Zhao H; Yan H
    BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
    Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities for translation: targeting DNA repair pathways in pancreatic cancer.
    Maginn EN; de Sousa CH; Wasan HS; Stronach EA
    Biochim Biophys Acta; 2014 Aug; 1846(1):45-54. PubMed ID: 24727386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples.
    Semaan A; Bernard V; Lee JJ; Wong JW; Huang J; Swartzlander DB; Stephens BM; Monberg ME; Weston BR; Bhutani MS; Chang K; Scheet PA; Maitra A; Jakubek YA; Guerrero PA
    Clin Cancer Res; 2021 Feb; 27(4):1082-1093. PubMed ID: 33188144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma.
    Wen C; Deng X; Ren D; Song X; Chen H; Wang J; Jin J; Cheng D; Xu Z; Zhang J; Xie J; Qi W; Gu J; Peng C; Chen D; Chen S; Shen B; Zhan Q
    Cancer Med; 2020 Oct; 9(20):7626-7636. PubMed ID: 32862515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis.
    Wei T; Zhang J; Li J; Chen Q; Zhi X; Tao W; Ma J; Yang J; Lou Y; Ma T; Li X; Zhang Q; Chen W; Que R; Gao S; Bai X; Liang T
    Mol Oncol; 2020 Sep; 14(9):1966-1977. PubMed ID: 32593194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
    Golan T; O'Kane GM; Denroche RE; Raitses-Gurevich M; Grant RC; Holter S; Wang Y; Zhang A; Jang GH; Stossel C; Atias D; Halperin S; Berger R; Glick Y; Park JP; Cuggia A; Williamson L; Wong HL; Schaeffer DF; Renouf DJ; Borgida A; Dodd A; Wilson JM; Fischer SE; Notta F; Knox JJ; Zogopoulos G; Gallinger S
    Gastroenterology; 2021 May; 160(6):2119-2132.e9. PubMed ID: 33524400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline genetic variability in pancreatic cancer risk and prognosis.
    Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D
    Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine and Pancreatic Cancer.
    George B
    Surg Oncol Clin N Am; 2021 Oct; 30(4):693-708. PubMed ID: 34511190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
    Fujii A; Masuda T; Iwata M; Tobo T; Wakiyama H; Koike K; Kosai K; Nakano T; Kuramitsu S; Kitagawa A; Sato K; Kouyama Y; Shimizu D; Matsumoto Y; Utsunomiya T; Ohtsuka T; Yamanishi Y; Nakamura M; Mimori K
    Cancer Sci; 2021 Apr; 112(4):1655-1668. PubMed ID: 33605496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.